novo nordisk semaglutide lawsuit drops its Hims & Hers patent as Wegovy and Ozempic head to the Hims platform Ozempic is under fire with

The approval was granted based on data that showed the drugs effectiveness against antimicrobial resistance in gram-negative bacteria, especially resistance mediated by both extended spectrum beta lactamases and AmpC, according to Allecras announcement

Three triple agonists are currently in clinical trials: retatrutide (Eli Lilly), HM15211 (Hanmi Pharmaceutical), and SAR441255 (Sanofi)

Reduces Dark Spots Helps fade blemishes and dark spots, promoting an even skin tone

Everyone started to complement me and I got my confidence back

No preservatives

Nutrition and Training Recommendations Peptides are tools, not magic